These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8459075)

  • 21. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.
    Grimm W; Flores BT; Marchlinski FE
    Circulation; 1993 Jun; 87(6):1880-8. PubMed ID: 8504500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.
    Mittal S; Iwai S; Stein KM; Markowitz SM; Slotwiner DJ; Lerman BB
    J Am Coll Cardiol; 1999 Oct; 34(4):1082-9. PubMed ID: 10520794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation.
    Lessmeier TJ; Lehmann MH; Steinman RT; Fromm BS; Akhtar M; Calkins H; DiMarco JP; Epstein AE; Estes NA; Fogoros RN
    Am Heart J; 1994 Aug; 128(2):211-8. PubMed ID: 8037084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.
    Wever EF; Hauer RN; Schrijvers G; van Capelle FJ; Tijssen JG; Crijns HJ; Algra A; Ramanna H; Bakker PF; Robles de Medina EO
    Circulation; 1996 Feb; 93(3):489-96. PubMed ID: 8565166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular arrhythmias and sudden cardiac death: an insight from recent multicenter randomized clinical trials.
    Akiyama T
    Keio J Med; 1996 Dec; 45(4):313-7. PubMed ID: 9023449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of literature.
    Autschbach R; Falk V; Gonska BD; Dalichau H
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):552-8. PubMed ID: 7513886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest.
    Chan PS; Krumholz HM; Spertus JA; Curtis LH; Li Y; Hammill BG; Nallamothu BK;
    Am Heart J; 2015 Jun; 169(6):870-878.e1. PubMed ID: 26027626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest.
    Mangi AA; Boeve TJ; Vlahakes GJ; Akins CW; Hilgenberg AD; Ruskin JN; McGovern BM; Torchiana DF
    Ann Thorac Surg; 2002 Nov; 74(5):1510-6. PubMed ID: 12440601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias.
    Link MS; Costeas XF; Griffith JL; Colburn CD; Estes NA; Wang PJ
    J Am Coll Cardiol; 1997 Feb; 29(2):370-5. PubMed ID: 9014991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of spontaneous recurrent ventricular arrhythmias detected by electrogram-storing defibrillators in sudden cardiac death survivors with no inducible ventricular arrhythmias at baseline electrophysiologic testing.
    Zaim S; Zaim B; Rottman J; Mendoza I; Nasir N; Pacifico A
    Am Heart J; 1996 Aug; 132(2 Pt 1):274-9. PubMed ID: 8701887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion.
    Yap SC; Sakhi R; Theuns DAMJ; Yasar YE; Bhagwandien RE; Diletti R; Zijlstra F; Szili-Torok T
    Heart Rhythm; 2018 Jan; 15(1):124-129. PubMed ID: 28917556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study.
    Bunch TJ; White RD; Friedman PA; Kottke TE; Wu LA; Packer DL
    Heart Rhythm; 2004 Sep; 1(3):255-9. PubMed ID: 15851165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.